Critical Care

Trusted pharma products in Critical Care

Cefoperazone+sulbactam for injaction

Strength: 1.5g

Form: solution for injection

Reference Brands:

View Details Get Enquiry

Cefotaxime

Strength: 250 mg, 500 mg, 1 g, 2 g

Form: IV and IM Injection

Reference Brands: Claforan(US)

View Details Get Enquiry

Cisatracurium Besylate Injection

Strength: 2 mg/ml

Form: Injection

Reference Brands:

View Details Get Enquiry

Colistimethate (Colistin)

Strength: 150 mg Colistin base activity (equivalent to 1 million IU)

Form: Intravenous (IV) Injection

Reference Brands: Coly-Mycin M(US); Colomycin(EU)

View Details Get Enquiry

Colistimethate Sodium for Injection

Strength: 1MIU/2MIU/3MIU/4.5MIU

Form: solution

Reference Brands:

View Details Get Enquiry

Dexmedetomidine

Strength: 100 mcg/mL

Form: Intravenous (IV) Infusion/Injection

Reference Brands: Precedex(US); Dexdor(EU)

View Details Get Enquiry

Dextrose (IV)

Strength: Dextrose 5% (D5W): 5 g/100 mL Dextrose 10% (D10W): 10 g/100 mL

Form: Intravenous (IV) Infusion Solution

Reference Brands: Dextrose (IV) Infusion Solutions

View Details Get Enquiry

Digoxin

Strength: 250 mcg/mL

Form: Intravenous (IV) Injection

Reference Brands: Lanoxin(US & EU)

View Details Get Enquiry

Digoxin

Strength: 62.5 mcg, 125 mcg, 250 mcg

Form: Tablets

Reference Brands: Lanoxin(US & EU)

View Details Get Enquiry

Dobutamine

Strength: 12.5 mg/mL

Form: Intravenous (IV) Injection

Reference Brands: Dobutrex(US), Dobutamina Hameln, Dobutamine Accord, Dobutamine Fresenius Kabi(EU)

View Details Get Enquiry

Dopamine

Strength: 40 mg/mL, 80 mg/mL, 160 mg/mL

Form: Intravenous (IV) Injection

Reference Brands: Intropin(US- dis.cntd but generics available); Dopamin-Hameln, Dopamina Normon, Dopamina Fresenius Kabi(EU)

View Details Get Enquiry

Enoxaparin

Strength: prefilled: 20 mg/0.2 mL, 40 mg/0.4 mL, 60 mg/0.6 mL, 80 mg/0.8 mL, 100 mg/1 mL

Form: Subcutaneous injection

Reference Brands: Lovenox®(US); Clexane®(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.